2016

   
  • Ritchie, H., Ragnerstam, C., Gustafsson, E., Jonsson, J., Webster, W. (2016). Control of the heart rate of rat embryos during the organogenic period. Hypoxia, 4, 147-159. [More Information]

2015

   
  • Ritchie, H., Oakes, D., Hung, T., Hegedus, E., Sood, S., Webster, W. (2015). The Effect of Dofetilide on the Heart Rate of GD11 and GD13 Rat Embryos, in vivo, Using Ultrasound. Birth Defects Research (Part B), 104(5), 196-203. [More Information]

2014

   
  • Ritchie, H., Svensson, C., Nilsson, M., Webster, W. (2014). A comparison of drug-induced cardiotoxicity in rat embryos cultured in human serum or protein free media. Journal of Pharmacological and Toxicological Methods, 70(3), 276-282. [More Information]
  • Nilsson, M., Webster, W. (2014). Effects of Macrolide Antibiotics on Rat Embryonic Heart Function In Vitro. Birth Defects Research (Part B), 101(2), 189-198. [More Information]
  • Webster, W., Nilsson, M., Ritchie, H. (2014). Therapeutic Drugs that Slow the Heart Rate of Early Rat Embryos. Is there a Risk for the Human? Current Pharmaceutical Design, 20(34), 5364-5376.

2013

   
  • Nilsson, M., Skold, A., Ericson, A., Annas, A., Villar, R., Cebers, G., Hellmold, H., Gustafson, A., Webster, W. (2013). Comparative effects of sodium channel blockers in short term rat whole embryo culture. Toxicology and Applied Pharmacology, 272(2), 306-312. [More Information]
  • Nilsson, M., Ritchie, H., Webster, W. (2013). The effect on rat embryonic heart rate of Na+, K+, and Ca2+ channel blockers, and the human teratogen phenytoin, changes with gestational age. Birth Defects Research (Part B), 98(5), 416-427. [More Information]
  • Ritchie, H., Ababneh, D., Oakes, D., Power, C., Webster, W. (2013). The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo. Birth Defects Research (Part B), 98(2), 144-153. [More Information]

2012

   
  • Ababneh, D., Ritchie, H., Webster, W. (2012). Antidepressants Cause Bradycardia and Heart Block in GD 13 Rat Embryos In Vitro. Birth Defects Research. Part B: Developmental and Reproductive Toxicology, 95(2), 184-193. [More Information]
  • Gunnstrom, M., Ababneh, D., Webster, W., Oakes, D., Ritchie, H. (2012). Antipsychotic drugs cause bradycardia in GD 13 rat embryos in vitro. Reproductive Toxicology, 34(3), 443-450. [More Information]

2010

   
  • Nilsson, M., Danielsson, C., Skold, A., Johansson, A., Blomgren, B., Wilson, J., Khan, K., Bengtsson, E., Kultima, K., Webster, W., et al (2010). Improved Methodology for Identifying the Teratogenic Potential in Early Drug Development of hERG Channel Blocking Drugs. Reproductive Toxicology, 29(2), 156-163. [More Information]
  • Abela, D., Ritchie, H., Ababneh, D., Gavin, C., Nilsson, M., Khan, M., Carlsson, K., Webster, W. (2010). The effect of drugs with ion channel-blocking activity on the early embryonic rat heart. Birth Defects Research. Part B: Developmental and Reproductive Toxicology, 89(5), 429-440. [More Information]

2009

   
  • Oakes, D., Ritchie, H., Woodman, P., Narup, E., Moscova, M., Picker, K., Webster, W. (2009). Genotoxicity studies of a desealant solvent mixture, SR-51. Toxicology and Industrial Health: An International Journal, 25(1), 5-13. [More Information]

2008

   
  • Jones, K., Webster, W., Vaux, K., Benirschke, K. (2008). Acardiac fetus: evidence in support of a vascular/hypoxia pathogenesis for isolated oral clefting. Birth Defects Research. Part A: Clinical and Molecular Teratology, 82(8), 597-600. [More Information]

2007

   
  • Karlsson, M., Danielsson, B., Nilsson, M., Danielsson, C., Webster, W. (2007). New Proposals for Testing Drugs with IKr-Blocking Activity to Determine Their Teratogenic Potential. Current Pharmaceutical Design, 13(29), 2979-2988. [More Information]
  • Webster, W., Abela, D. (2007). The effect of hypoxia in development. Birth Defects Research. Part C: Embryo Today Reviews, 81(3), 215-228. [More Information]

2006

   
  • Webster, W., Howe, A., Abela, D., Oakes, D. (2006). The relationship between cleft lip maxillary hypoplasia, hypoxia and phenytoin. Current Pharmaceutical Design, 12(12), 1431-1448. [More Information]

2005

   
  • Abela, D., Howe, A., Oakes, D., Webster, W. (2005). Maternal antioxidant supplementation does not reduce the incidence of phenytoin-induced cleft lip and related malformations in rats. Birth Defects Research. Part B: Developmental and Reproductive Toxicology, 74(2), 201-206. [More Information]

2004

   
  • Moscova, M., Oakes, D., Pollak, J., Webster, W. (2004). Effects of a desealant formulation, SR-51 and its individual components on the oxidative functions of mitochondria. Environmental Toxicology and Pharmacology, 18(2), 181-184.
  • Howe, A., Hawkins, J., Webster, W. (2004). The Growth Of The Nasal Septum In The 6-9 Week Period Of Foetal Development--Warfarin Embryopathy Offers A New Insight Into Prenatal Facial Development. Australian Dental Journal, 49(4), 171-176.

2003

   
  • Webster, W., Freeman, J. (2003). Prescription drugs and pregnancy. Expert Opinion on Pharmacotherapy, 4(6), 949-961. [More Information]

2002

   
  • Oakes, D., Webster, W., Woodman, P., Ritchie, H. (2002). A Study of the Potential for a Herbicide Formulation Containing 2,4-D and Picloram to Cause Male-Mediated Developmental Toxicity in Rats. Toxicological Sciences, 68(1), 200-206. [More Information]
  • Oakes, D., Webster, W., Woodman, P., Ritchie, H. (2002). Testicular changes induced by chronic exposure to the herbicide formulation, Tordon 75D(R) (2,4-dichlorophenoxyacetic acid and picloram)in rats. Reproductive Toxicology, 16(3), 281-289. [More Information]

2001

   
  • Webster, W., Freeman, J. (2001). Is this drug safe in pregnancy? Reproductive Toxicology, 15 (6), 619-629.
  • Oakes, D., Webster, W., Woodman, P., Ritchie, H. (2001). Male mediated developmental toxicity and the herbicide formulation, Tordon 75D. Australian Birth Defects Society, : World Scientific Publishing.